| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President &C.e.o.
2 companies
Capone Mark Christopher is a President &C.e.o. at MYRIAD GENETICS INC with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 7 sells.
Estimated insider holdings value: $2.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2019 | MYGN Myriad Genetics Inc | President &C.e.o. | Sale+OE | 137,000 | $44.00 | $6,028,000.00 | -7.2% | |
| Jul 11, 2018 | MYGN Myriad Genetics Inc | President &C.e.o. | Sale+OE | 80,000 | $41.00 | $3,280,000.00 | -10.7% | |
| May 30, 2018 | MYGN Myriad Genetics Inc | President &C.e.o. | Sale+OE | 90,000 | $38.00 | $3,420,000.00 | -21.3% | |
| Aug 19, 2016 | MYGN Myriad Genetics Inc | President &C.e.o. | Buy | 10,000 | $21.24 | $212,400.00 | +7.4% |